ALNYLAM PHARMACEUTICALS, INC. : BERNSTEIN CUTS TO MARKET-PERFORM FROM OUTPERFORM; CUTS TARGET PRICE TO $199 FROM $376

Reuters · 6d ago

Please log in to view news